Dec 02 2022
The prior use of cannabis “results in a decreased need for blood pressure support during general anesthesia”, finds a study published in the peer-reviewed journal Cannabis and Cannabinoids Research, with the full text of the study published on the website for the National Library of Medicine. According to researchers, this retrospective study “focuses on the …
Dec 01 2022
According to a new peer-reviewed study the cannabis compounds THC and CBN (cannabinol) induced apoptosis (cell death) in an animal model of cholangiocarcinoma (bile duct cancer). The study was published in the journal Evidence-Based Complementary and Alternative Medicine, and was conducted by researchers at Rangsit University, Bumrungrad International Hospital and Thammasat University, all in Thailand. …
Nov 28 2022
Cannabidiol (CBD) has “direct antineoplastic [cancer treating] effects on lung cancer cells”, according to a new study being published in the upcoming issue of the Iranian Biomedical Journal. The study was epublished ahead of print on the website for the U.S. National Institute of Health. “Lung cancer remains a major factor contributing to morbidity and …
Nov 25 2022
A new study has found that CBD reduces seizures in patients with Dravet syndrome (SD), Lennox-Gataut syndrome (LGS), or tuberous sclerosis complex (TSC), who are resistant to common medications. Published by the journal Revista da Associação Médica Brasileira and epublished by the National Library of Medicine, the study was conducted by researchers at Medicina Baseada …
Nov 21 2022
Cannabinoids may induce immunogenic cell death indicating they may be useful in combatting cancer. This is according to a new study being published in the upcoming issue of the peer-reviewed journal Cannabis and Cannabinoids Research. The study was epublished by the National Institute of Health, and “is the first demonstration that cannabinoids can induce the …
Nov 20 2022
Oral cannabinoid therapy seems to be safe and at least mildly effective in patients with treatment refractory chronic pain, according to a new European Journal of Pain study. “Cannabinoids are considered a therapeutic option to patients suffering from treatment refractory chronic pain (TRCP) insufficiently relieved by conventional analgesics or experiencing intolerable adverse events (AEs) from …
Nov 18 2022
Cannabidiol (CBD) enriched with terpenes may provide a safe and effective treatment option for autism spectrum disorder and is more effectice than CBD alone. This is according to a case report study being published in the journal Frontiers in Pharmacology and epublished by the U.S. National Library of Medicine. “Cannabidiol (CBD) rich products are successfully …
Nov 17 2022
Legalizing recreational marijuana at the state level doesn’t have a significant impact on crime rates, according to a new study published in the Journal of Drug Issues. For the study researchers affiliated with the University of Colorado and Boise State University compared crime data in Colorado and Washington – the first two states to legalize marijuana …
Nov 14 2022
According to a study epublished by the U.S. National Library of Medicine, “administration of the phytocannabinoid Δ9THC promotes significant recovery from TBI (traumatic brain injury).” Conducted by researchers at the University of South Florida and the James Haley VA Medical Center, the study was published in a recent issue of the peer-reviewed journal Cannabis and …
Nov 13 2022
A new study conducted by researchers at the Penn State College of Medicine has found that while CBD alone is not incredibly effective at treating neuropathic pain, it is effective when mixed with THC, and THC is effective when administered by itself. Published by the journal Biomedicines, the full text of the study can be found …
